In terms of revenue, the Global 4D Printing in Healthcare Market is expected to reach USD 35.8 Million by 2028, growing at a Compound Annual Growth Rate (CAGR) of 26.7% from 2022 to 2028. Increasing technological advancements in 4D printing technology, such as the development of smart, programmable materials are the driving factors for the market.

Key Findings:

• Under the technology segment polyjet sub-segment is anticipated to dominate the segment for the market and grow at a substantial CAGR. This technology allows for the development of complex forms with intricate components and delicate features. It delivers products with a variety of materials type within a single model.
• Medical & research models sub-segment held a market significant share in 2021. This is the fastest segment growing in the market as these models can be customized as per the patient’s pathology, which further helps in delivering efficient patient will care.
• North America is the largest regional segment. This is due to its increased favorable reimbursement system, and technological improvements in the region.

Some of key players in Market include - D Systems (US), Organovo Holdings Inc. (US), Stratasys Ltd. (US & Israel), Dassault Systèmes (France), Materialise (Belgium), EOS GmbH Electro Optical Systems (Germany), EnvisionTEC (Germany), and Poietis (France).

The use of 4D printing technology to make smart medical models is anticipated to drive market growth. The development of programmable materials as this technology can be valuable for creating biocompatible products for the body. Also, 4D printing could be broadly utilized for the targeted drug delivery systems where the mixture of the pharmaceutical drugs is constructed such that they act only on a targeted site in the body. Thus, the industry is guiding the medical sector to make new inventive drug delivery systems and enhanced efficiency for the treatments.

The growing demand for inventions in organ transplants is a driving factor for the industry. Production of functional implants considering biocompatibility, biomedical splits, stents, and in developing areas of tissue engineering and self-assembling human-scale biomaterials are the primary element predicting the industry growth. Moreover, complicated therapies such as cancer chemotherapy and technology reduce the surgical techniques are also driving the 4D printing industry enormously.

North America is expected to emerge as potential market for market. This is majorly due to the ongoing technological advancements, increasing demand for organ transplantation, actions are taken in the analysis & development of the 4D printing technology in the medical sector, and the existence of favorable developed medical infrastructure in the region.